Insider screener

Period: 12 months Type of trade: Sold × Plan: Not on a plan × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,362 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,362 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,362 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,362 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,362 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,362 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,362 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
12 Mar 2026
Lori Winkler SVP and CHRO
Sold at will
$250.85K 2,650 at 94.66
20.6%
Not planned
12 Mar 2026
Gary W. Mize Director
Sold at will
$250.08K 107,100 at 2.34
27.6%
Not planned
12 Mar 2026
Sold at will
$246.25K 8,500 at 28.97
36.9%
Not planned
12 Mar 2026
Ricky D. Hessling Chief Commercial Officer
Sold at will 2×
$237.55K 1,037 at 229.08
10.2%
Not planned
12 Mar 2026
Deneen L Donnley SVP and General Counsel
Sold at will
$218.99K 1,922 at 113.94
5.6%
Not planned
12 Mar 2026
Thomas M Siebel Executive Chairman
Sold at will
$213.49K 23,435 at 9.11
3.1%
Not planned
12 Mar 2026
Elizabeth Loveman SVP and Controller
Sold at will
$210.94K 4,053 at 52.04
19.6%
Not planned
12 Mar 2026
Mariya Pylypiv Chief Financial Officer
Sold at will
$205.97K 20,078 at 10.26
28.7%
Not planned
12 Mar 2026
Charles L King SVP & Chief Technology Officer
Sold at will
$200.53K 2,440 at 82.19
11.7%
Not planned
12 Mar 2026
Prashant Nateri Chief Corp Operations Officer
Sold at will
$157.65K 10,171 at 15.50
10.8%
Not planned
12 Mar 2026
Vinayak Doraiswamy Chief Scientific Officer
Sold at will
$149.15K 5,000 at 29.83
4.9%
Not planned
12 Mar 2026
Dean C Kehler Director
Sold at will
$143.16K 16,200 at 8.84
12.7%
Not planned
12 Mar 2026
David Mountcastle EVP & Chief Financial Officer
Sold at will
$141.32K 6,453 at 21.90
2.7%
Not planned
12 Mar 2026
Stephen Mayo Director
Sold at will
$123.21K 7,239 at 17.02
80.4%
Sold half or more
12 Mar 2026
Sold at will
$120.37K 3,600 at 33.44
29.3%
Not planned
12 Mar 2026
Brooks J Klimley Director
Sold at will
$115.80K 5,000 at 23.16
6.7%
Not planned
12 Mar 2026
Sanjiv Das President
Sold at will
$106.62K 9,702 at 10.99
6.3%
Not planned
12 Mar 2026
Sold at will
$100.16K 332 at 301.70
13.1%
Not planned
12 Mar 2026
Denis Garagic Chief Technology Officer
Sold at will
$97.73K 12,945 at 7.55
2.1%
Not planned
12 Mar 2026
Eric A Fisher SVP · indirect
Sold at will 2×
$95.44K 400 at 238.60
100%
Sold half or more
12 Mar 2026
John w Raymond Director
Sold at will
$93.35K 2,800 at 33.34
3.2%
Not planned
12 Mar 2026
Evangelos Perros Chief Financial Officer
Sold at will
$92.59K 8,425 at 10.99
7.0%
Not planned
12 Mar 2026
Sold at will
$81.80K 3,566 at 22.94
38.1%
Not planned
12 Mar 2026
Charles Do Sr. Vice President, HDFSI
Sold at will
$76.74K 4,241 at 18.10
95.9%
Sold half or more
12 Mar 2026
Jennifer Baldock Chief Admin & Dev Officer
Sold at will
$76.36K 5,798 at 13.17
1.7%
Not planned
12 Mar 2026
Ronna Romney Director · indirect
Sold at will
$74.34K 506 at 146.92
2.9%
Not planned
12 Mar 2026
Sold at will
$72.71K 340 at 213.77
3.2%
Not planned
12 Mar 2026
Robert L. Scavo Chief Information Officer
Sold at will 2×
$70.55K 4,044 at 17.45
0.8%
Not planned
12 Mar 2026
Tami Rosen Chief Development Officer
Sold at will
$64.90K 5,905 at 10.99
11.1%
Not planned
12 Mar 2026
Martin C. Schoch EVP of Supply Chain
Sold at will
$61.08K 11,321 at 5.40
24.8%
Not planned
12 Mar 2026
Trevor Thatcher Chief Financial Officer
Sold at will
$57.75K 7,649 at 7.55
4.0%
Not planned
12 Mar 2026
Mika Nishimura Director
Sold at will
$56.70K 4,100 at 13.83
11.1%
Not planned
12 Mar 2026
Mark Romaine Chief Operating Officer
Sold at will
$54.60K 1,148 at 47.56
0.7%
Not planned
12 Mar 2026
Stephen Sonne Chief Legal Officer
Sold at will
$51.36K 6,802 at 7.55
3.2%
Not planned
12 Mar 2026
Ronna Romney Director
Sold at will 2×
$49.02K 2,000 at 24.51
6.9%
Not planned
12 Mar 2026
James D. Klein President, CRBT
Sold at will
$45.71K 554 at 82.50
42.9%
Not planned
12 Mar 2026
Sold at will
$42.83K 3,766 at 11.37
100%
Sold half or more
12 Mar 2026
Samuel Yount Chief Business Officer · indirect
Sold at will 2×
$31.94K 3,011 at 10.61
1.5%
Not planned
12 Mar 2026
Gregory Russotti See Remarks
Sold at will
$25.68K 10,076 at 2.55
1.9%
Not planned
12 Mar 2026
Douglas Carr SVP Finance & Operations
Sold at will
$17.95K 7,043 at 2.55
1.4%
Not planned
12 Mar 2026
International Finance Corp 10% owner · indirect
Sold at will
$13.28K 2,839 at 4.68
0.0%
Not planned
12 Mar 2026
Jaehyun Park Chief Financial Officer
Sold at will
$12.37K 958 at 12.91
100%
Sold half or more
12 Mar 2026
Tiah Norton Reppas Chief Accounting Officer
Sold at will
$10.06K 6,250 at 1.61
33.5%
Not planned
12 Mar 2026
Sold at will
$9.30K 1,002 at 9.28
0.2%
Not planned
12 Mar 2026
Amy W Schulman Director
Sold at will
$7.48K 26 at 287.50
10.7%
Not planned
12 Mar 2026
Jodi Devlin Chief of Clinical Operations
Sold at will
$7.25K 1,772 at 4.09
1.8%
Not planned
12 Mar 2026
Richard Marshak Chief Commercial Officer
Sold at will
$6.50K 1,589 at 4.09
1.4%
Not planned
12 Mar 2026
Jennifer Stevens Chief Regulatory Officer
Sold at will
$6.35K 1,552 at 4.09
1.2%
Not planned
12 Mar 2026
Bryan F. Cox Chief of Research
Sold at will
$6.00K 1,467 at 4.09
0.9%
Not planned
12 Mar 2026
Dean C Kehler Director · indirect
Sold at will
$4.40K 500 at 8.80
0.4%
Not planned
Showing 14,501–14,550 of 23,362. ← Newer Page 291 of 468 Older →